A star-PEG–heparin hydrogel platform to aid cell replacement therapies for neurodegenerative diseases

Abstract Biofunctional matrices for in vivo tissue engineering strategies must be modifiable in both biomolecular composition and mechanical characteristics. To address this challenge, we present a modular system of biohybrid hydrogels based on covalently cross-linked heparin and star-shaped poly(et...

Full description

Saved in:
Bibliographic Details
Published in:Biomaterials Vol. 30; no. 28; pp. 5049 - 5060
Main Authors: Freudenberg, Uwe, Hermann, Andreas, Welzel, Petra B, Stirl, Katja, Schwarz, Sigrid C, Grimmer, Milauscha, Zieris, Andrea, Panyanuwat, Woranan, Zschoche, Stefan, Meinhold, Dorit, Storch, Alexander, Werner, Carsten
Format: Journal Article
Language:English
Published: Netherlands Elsevier Ltd 01-10-2009
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Biofunctional matrices for in vivo tissue engineering strategies must be modifiable in both biomolecular composition and mechanical characteristics. To address this challenge, we present a modular system of biohybrid hydrogels based on covalently cross-linked heparin and star-shaped poly(ethylene glycols) (star-PEG) in which network characteristics can be gradually varied while heparin contents remain constant. Mesh size, swelling and elastic moduli were shown to correlate well with the degree of gel component cross-linking. Additionally, secondary conversion of heparin within the biohybrid gels allowed the covalent attachment of cell adhesion mediating RGD peptides and the non-covalent binding of soluble mitogens such as FGF-2. We applied the biohybrid gels to demonstrate the impact of mechanical and biomolecular cues on primary nerve cells and neural stem cells. The results demonstrate the cell type-specific interplay of synergistic signaling events and the potential of biohybrid materials to selectively stimulate cell fate decisions. These findings suggest important future uses for this material in cell replacement based-therapies for neurodegenerative diseases.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0142-9612
1878-5905
DOI:10.1016/j.biomaterials.2009.06.002